Drug-Induced Movement Disorders in Elderly Patients

SANTIAGO PEREZ LLORET; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL

Movement Disorders in Dementia

Springer

Año: 2013; p. 200 - 231

Movement disorders such as dystonia, akathisia, parkinsonism, chorea, stereotypies, myoclonus, or tics can be observed during exposure to a large number of drugs commonly used for the treatment of diverse medical conditions. The most frequent drugs connected to movement disorders are antipsychotics, but they can also be observed with a variety of drugs, such as metoclopramide, prochlorperazine, cinnarizine, flunarizine, H1 antihistaminergic drugs, trimetazidine, or serotonin reuptake inhibitors. Clinical observation is crucial for differential diagnosis of drug-induced movement disorders. Neuroimaging by positron emission tomography (PET) or single photon emission computed tomography (SPECT) may be of help for diagnosing druginduced parkinsonism or tardive dyskinesia. The first therapeutic measure is to withdraw the offending drug when possible. When needed, muscarine receptor blockers can be used to treat acute dystonia, propranolol or alprazolam for akathisia, and reserpine or methyldopa for life-threatening tardive syndromes.